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Humans are continuously exposed to airborne spores of the saprophytic fungus
Aspergillus fumigatus. However, in healthy individuals pulmonary host defense
mechanisms efficiently eliminate the fungus. In contrast, A. fumigatus causes
devastating infections in immunocompromised patients. Host immune responses
against A. fumigatus lung infections in immunocompromised conditions have remained
largely elusive. Given the dynamic changes in immune cell subsets within tissues
upon immunosuppressive therapy, we dissected the spatiotemporal pulmonary immune
response after A. fumigatus infection to reveal basic immunological events that fail
to effectively control invasive fungal disease. In different immunocompromised murine
models, myeloid, notably neutrophils, and macrophages, but not lymphoid cells were
strongly recruited to the lungs upon infection. Other myeloid cells, particularly dendritic
cells and monocytes, were only recruited to lungs of corticosteroid treated mice, which
developed a strong pulmonary inflammation after infection. Lymphoid cells, particularly
CD4+ or CD8+ T-cells and NK cells were highly reduced upon immunosuppression
and not recruited after A. fumigatus infection. Moreover, adoptive CD11b+ myeloid cell
transfer rescued cyclophosphamide immunosuppressed mice from lethal A. fumigatus
infection but not cortisone and cyclophosphamide immunosuppressed mice. Our
findings illustrate that CD11b+ myeloid cells are critical for anti-A. fumigatus defense
under cyclophosphamide immunosuppressed conditions.
Keywords: Aspergillus fumigatus, immune cell recruitment, CD11b+ myeloid cells, corticosteroids and
cyclophosphamide
INTRODUCTION
Respiratory lung infections caused by the pathogenic mold Aspergillus fumigatus result in
life-threatening complications in immunocompromised patients, for instance, after allogeneic
hematopoietic cell transplantation, solid organ transplantation, chemotherapy for cancer, or
other acquired or congenital immune disorders (Nihtinen et al., 2010; Kousha et al., 2011;
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Singh et al., 2013). A. fumigatus is a ubiquitous, airborne
saprophytic fungus, which produces thousands of conidia with
every conidiophore (Latge, 1999). The conidia are rapidly
released into the environment. Their hydrophobic exterior and
small diameter of 2–3µm facilitates them to reach the lung alveoli
easily by crossing physiological barriers (Latge, 1999; Dagenais
and Keller, 2009; Park and Mehrad, 2009). However, healthy
individuals do not develop invasive lung infections despite a
continuous exposure to fungal spores (Garcia-Vidal et al., 2013)
without signs of antibody- or cell-mediated adaptive immune
response or symptoms attributable to A. fumigatus inhalation
(Park and Mehrad, 2009). A steadily increasing population of
immunocompromised patients is at greater risk and experiences
life-threatening invasive infections by A. fumigatus. Although,
several antifungal drugs have become available to combat
A. fumigatus infections, the mortality of this devastating disease
remains as high as 90% in immunocompromised patients
(Dagenais and Keller, 2009). Efforts to improve management
and treatment of A. fumigatus lung infections are mostly
concentrated on identification of new antifungal drug targets
and compounds (Segal et al., 2006). However, it appears
essential to develop therapies that improve the host immune
defense in immunocompromised patients. To this end, an in-
depth understanding of the dynamic host immune responses
against A. fumigatus lung infections under immunocompromised
condition is a prerequisite for successful applications of novel
therapeutic strategies to effectively manage and treat lung
infections in high-risk immunocompromised patients.
Due to various clinical therapies, patient numbers requiring
the administration of immunosuppressive drugs are constantly
increasing. The most commonly used immunosuppressive
drugs in clinical situations with various conditions are
cyclophosphamide and corticosteroids (Barnes, 2006; Emadi
et al., 2009; Shaikh et al., 2012). Cyclophosphamide is a widely
used antineoplastic drug and potent immunosuppressive agent
used in the treatment for a wide range of diseases such as
solid tumors, hematologic malignancies, autoimmune disorders
and as a conditioning regimen for stem cell mobilization
and hematopoietic cell transplantation (Emadi et al., 2009).
Corticosteroids have proven as most effective anti-inflammatory
treatment for asthma and for a number of other inflammatory
and immune diseases (Barnes, 2006). Some clinical therapies
also use a combination of cyclophosphamide and corticosteroids
(Thone et al., 2008). The differences in A. fumigatus infection and
inflammatory response in corticosteroid and chemotherapeutic
models of invasive aspergillosis have been addressed previously;
however these analyses focused on immune cells and cytokines
contained in the bronchoalveolar lavage fluid after infection
(Balloy et al., 2005). Despite the widespread clinical use,
knowledge remains limited on how these immunosuppressive
treatments modulate immune cell recruitment after lethal
A. fumigatus lung infection.
The most frequent source of invasive pulmonary infection
is the inhalation of conidia into the lungs and sinuses (Latge,
1999). The small size of A. fumigatus conidia and their
hydrophobic protein coat layer conceals immune stimulatory
polysaccharides and protect them from host defense (Enoch
et al., 2006; Aimanianda et al., 2009). The virulence of
A. fumigatus is multifactorial, and it depends on both host and
fungal properties (Abad et al., 2010). However, host immune
status is a key determinant for the initiation and outcome of
infection. Host immunosuppression allows the germination of
A. fumigatus conidia and subsequent development to hyphae,
which leads to invasive lung infection. Therefore, the host
immune response at the site of infection is a key factor for the
fate of A. fumigatus conidia in the lung tissue. However, the
timing and magnitude of host immune cell responses following
A. fumigatus conidial inhalation, as well as continuous host
defense throughout the different developmental stages of fungi
in immunocompromised conditions remain poorly defined.
The innate immune response is crucial to clear A. fumigatus
infection (Margalit and Kavanagh, 2015). The adoptive transfer
of myeloid progenitors protect against A. fumigatus infections
in chemically induced neutropenic mouse models (BitMansour
et al., 2002; BitMansour et al., 2005) and this protective effect
is mediated across major histocompatibility complex barriers
(Arber et al., 2005). However, transfused myeloid precursors have
to differentiate into effector cells to fight against infection. In
contrast, adoptively transferred terminally differentiated myeloid
cells may not survive for longer time periods to completely clear
infection. Thus, the transfusion of a mixed myeloid population
that consists of undifferentiated precursors and terminally
differentiated effector cells might be an ideal approach to fight
against A. fumigatus infections. However, to date this approach
has not been investigated. Here, we employed a combination
of murine in vivo models to investigate immune cell responses
following respiratory fungal challenge with A. fumigatus conidia
under different immunosuppressive regimens. We show that
CD11b+ myeloid cells are critical for anti-A. fumigatus defense
in immunocompromised conditions and that adoptive CD11b+
myeloid cell transfer into cyclophosphamide immunosuppressed
mice rescues mice from lethal A. fumigatus infection.
MATERIALS AND METHODS
Animals
Inbred BALB/c female mice were purchased from Charles River
(Sulzfeld, Germany) and maintained in the pathogen-free animal
facility of the Institute for Molecular Infection Biology (IMIB),
University of Würzburg, Germany. Firefly luciferase transgenic
BALB/c.L2G85 female mice had been backcrossed from
FVB/N.L2G85 mice for more than 12 generations (Cao et al.,
2004; Beilhack et al., 2005). All experiments were performed with
8–12-week-old female mice. All animal experiments were carried
out according to German guidelines for animal experimentation.
The responsible authority (Regierung von Unterfranken; Permit
Number 55.2-2531.01-86-13) approved the study.
Immunosuppressive Treatments
In the cyclophosphamide and corticosteroid treated (CCT)
model, mice were intraperitoneally injected with 150 mg kg−1
cyclophosphamide (Sigma–Aldrich, Munich, Germany) and
subcutaneously (s.c.) with 112 mg kg−1 hydrocortisone acetate
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(Sigma–Aldrich) on days -3 and -1 before A. fumigatus infection.
In the corticosteroid treated (CT) model, mice were s.c. injected
with 112 mg kg−1 hydrocortisone acetate on days -3 and -1 before
infection.
Fungal Strains and Infection
The clinical isolate of A. fumigatus ATCC46645 strain (Hearn and
Mackenzie, 1980) was routinely used. Fluorescent A. fumigatus
strain Afu-TdTomato (Lother et al., 2014) generated from
ATCC46645 (kindly provided by Dr. Sven Krappmann) was
used to determine fungal developmental stages inside lung
tissue. All the fungal strains were cultivated on defined minimal
medium (Amich et al., 2013) under standard culture conditions
and handled according to German laboratory safety guidelines.
Conidia were harvested from sporulating mycelium using the
standard saline/0.01% tween solution, filtered through cell
strainer and finally washed with sterile saline. Mice were
anesthetized by intraperitoneal injection of ketamine (50 µg/g
bodyweight) and xylacine (5 µg/g bodyweight) in 0.1 M
phosphate-buffered saline (PBS) in a total volume of 10 µl/g
bodyweight and intra-nasally infected with 1 × 106 conidia
suspended in 50 µl saline/0.01% tween. All infected mice were
monitored carefully according to the standard guidelines; briefly,
mice were regularly observed twice a day and carefully monitored
for weight loss and disease symptoms. In the immune cell
recruitment studies at least n= 3/group of mice were used in each
independent experiment and data are pooled from three different
experiments. In survival studies at least n= 5/group of mice were
used in each independent experiment.
Preparation of Lung Single Cell
Suspensions for FACS
Single cell suspensions were prepared from lungs according to the
previously described protocol (Stockmann et al., 2010) with some
modifications. Briefly, left and right lung lobes were dissected
from euthanized mice and finely minced using surgical blades
in six well-tissue culture plates containing RPMI medium (Life
Technologies, USA), then enzymatically digested for 30 min at
37◦C in presence of 2 mg/ml Collagenase D and 0.1 mg/ml
DNase I (Roche, Mannheim, Germany), diluted with PBS + 0.5
% BSA, filtered through a 70 µm cell strainer (Greiner bio-one,
Frickenhausen, Germany) and centrifuged at 1200 rpm for 5 min.
The lung cell pellet was re-suspended in erythrocyte lysis buffer
(168 mM NH4Cl, 10 mM KHCO3, 0.1 mM ethylene diamine
tetra acetic acid (EDTA)) for 2 min, and immediately diluted
with double the volume of PBS and centrifuged. Finally, single
cell suspensions were diluted to desired volumes suitable for flow
cytometry analyses.
Flow Cytometry Analysis
Cells were blocked with normal rat serum (1: 20 in PBS) and
stained with appropriate antibodies at 4◦C for 30 min. To
discriminate live/dead cells, they were stained with LIVE/DEAD
fixable violet dead cell stain kit (Invitrogen). All the antibodies
used were from Biolegend (Uithoorn, The Netherlands).
Antibodies (clones) utilized are listed below: CD90.2-PE
(30-H12), CD4-APC/Cy7 (GK1.5), CD8-APC/Cy7 (53–6.7),
CD11b-perCP-Cy5.5 (M1/70), CD11b-PE (M1/70) CD11c-
FITC (N418), I-A/I-E-PE/Cy7 (M5/114.15.2), SiglecF-APC (E50-
2440), Ly-6G-APC (1A8), FITC-Ly-6C (HK1.4), Ly6C-PerCP-
Cy5.5 (HK1.4), F4/80-APC/Cy7 (BM8), CD49b-PE/Cy7 (DX5).
All experiments were carried out using a BD fluorescence-
activated cell sorting (FACS) Canto II (BD Biosciences) and data
was recorded using BD FACS Diva software and analyzed using
FlowJo software version 8.0 (Tree Star, Ashland, OR, USA).
Immunofluorescence Microscopy
Cryo-embedded lung tissues were cut into 8 µm thick sections
on a Leica CM1900 cryostat (Leica Microsystems, Wetzlar,
Germany) and mounted onto frosted slides. Slides were air-dried
and fixed with acetone at room temperature for 7 min. Slides
were counterstained with 4′,6-diamidino-2-phenylindole (DAPI)
and mounted with mounting medium (Vector Laboratories,
Peterborough, UK) or stained with hematoxylin and eosin.
Luciferase expressing CD11b+ myeloid cells were stained with
an anti-luciferase antibody (Abcam, USA) and the secondary
Goat anti-Rabbit IgG, FITC-conjugated antibody (Abcam, USA)
according to the manufacturer’s instructions. To detect apoptotic
cells TUNEL staining was performed with a commercial
kit (Roche Diagnostics, Mannheim, Germany) according to
manufacturer’s instructions. Images were taken using Z1
fluorescence microscope (Carl Zeiss, Gottingen, Germany) and
evaluated with Zeiss AxioVision software (Carl Zeiss).
Cytometric Bead Array
Lungs were homogenized in 500 µl PBS using Precellys
ceramic kit 1.4 mm in a Precellys 24 homogenizer. Serum
was separated from cell debris by 10 min centrifugation at
13000 rpm 4◦C and immediately stored at −80◦C until further
use. Cytokine/chemokine concentrations were measured using
BD Cytometric Bead Array Kit (BD Pharmingen, Heidelberg,
Germany) or Biolegend Multiplex assay kit (Biolegend, Uithoorn,
The Netherlands) according to the manufacturer’s instructions.
Data were analyzed by FCAP Array v2.0 software.
Isolation of CD11b+ Myeloid Cells and
Adoptive Transfer
Mouse CD11b+ myeloid cells were enriched from bone
marrow (flushed from femur and tibia bones with PBS) of
healthy untreated or hydrocortisone-treated BALB/c mice, using
myeloid cell enrichment kit (STEMCELL Technologies, Cologne,
Germany) according to manufacturer’s instructions. Cell purity
was confirmed by post-enrichment FACS analysis (>90%) in
all the experiments. Enriched cells were adoptively transferred
via retro-orbital i.v. injection after mice were anesthetized by
intraperitoneal injection of ketamine (50 µg/g bodyweight) and
xylacine (5 µg/g bodyweight) in 0.1 M Phosphate-Buffered Saline
(PBS) in a total volume of 10 µl/g bodyweight.
Bioluminescence Imaging
Ex vivo lung bioluminescence imaging was performed as
previously described (Chopra et al., 2013, 2015). Briefly, mice
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FIGURE 1 | Immunocompromised mouse models to investigate the dynamic host immune response and survival after Aspergillus fumigatus
infection. (A) Experimental setup. BALB/c mice were treated with hydrocortisone (112.5 mg kg−1) on day -3 and day -1 (CT mice) or with cyclophosphamide
(150 mg kg−1) and hydrocortisone (112.5 mg kg−1) on day -3 and day -1 before A. fumigatus infection (CCT mice). On day 0 mice were intranasally infected with
1 × 106 conidia/mouse. Pulmonary immune cell and cytokine responses were analyzed at 4, 16, and 40 h post infection (p.i.). Survival was followed for 12 days p.i.
(B) A. fumigatus developmental stages inside lung tissue. Immunofluorescence microscopy of lungs from immunosuppressed mice that were infected with
Afu-TdTomato conidia at 4, 16, and 40 h p.i. Upper panel CT mice and lower panel CCT mice, A. fumigatus in red color and 4′,6-diamidino-2-phenylindole (DAPI)
(Continued)
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FIGURE 1 | Continued
staining for nuclei in blue color. Scale bar 10 µM. (C) Lung immune cell infiltration in IC, CT, and CCT infected mice: Lung sections were stained with hematoxylin &
eosin at 40 h p.i. and imaged in bright field microscope. Scale bar 200 µM. (D) Survival of mice under different immunosuppressive regimens: immunocompetent
infected (IC infected), corticosteroid treated and infected (CT infected), and cyclophosphamide and corticosteroid treated and infected (CCT infected); (n = 5/group).
Immunocompetent mice (IC) are resistant to infection, whereas CT (P = 0.0004) and CCT (P < 0.0001) mice succumb to invasive aspergillosis. However, CT mice
survive infection significantly longer than CCT mice (P < 0.0001). When mice lost ≥20% weight, they reached an experimental end point and were euthanized
according to animal ethics regulations. Log-rank (Mantel–Cox) test was utilized to determine differences in survival.
were injected with 300 mg/kg D-luciferin and euthanized after
10 min to prepare lungs and immediately subjected to ex vivo
bioluminescence imaging with an IVIS Spectrum imaging system
(Perkin–Elmer/Caliper Life Sciences, Mainz, Germany). Images
were evaluated with Living Image 4.0 software (Caliper Life
Sciences).
Statistical Analyses
All the measurements are expressed as the mean ± standard
deviation (SD). Statistical analyses were performed using Graph
Pad Prism 6 (Groningen, The Netherlands) software. To compare
cell numbers between the two different groups the unpaired
Mann–Whitney u-test was applied. Significant differences are
marked as follows: ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001. To
compare survival curves of infected mice, the Log-rank (Mantel-
Cox) test was utilized.
RESULTS
Immunocompromised Murine Models to
Study A. fumigatus Lung Infections
To explore how immunosuppressive therapy affects
pulmonary control of A. fumigatus infection, we compared
immunocompetent mice with two different immunosuppressed
mouse models (Figure 1A). Firstly, cyclophosphamide and
cortisone treated (CCT) mice and, secondly, corticosteroid
treated (CT) mice to investigate pulmonary host immune
responses following respiratory A. fumigatus infection. We
examined different morphotypes of fungal developmental stages
in infected lung sections at 4, 16, and 40 h post-infection (p.i.)
time points with immunofluorescence microscopy. We observed
fungal differentiation from conidia at 4 h p.i. to germlings at 16 h
p.i., and hyphae at 40 h p.i. in CT infected lung sections and
CCT infected lung sections (Figure 1B). However, we observed
elongated filaments (hyphal growth) in CCT mice at 16 h and
more clearly at 40 h (Figure 1B) compared to CT infected mice.
Strikingly, these results suggested that different numbers or types
of immune cells might have been recruited to lungs of CT infected
mice to restrict the hyphal growth. Qualitative hematoxylin &
eosin staining of lung sections from immunocompetent, CT
and CCT mice at 40 h p.i. exhibited different levels of infiltrated
lung immune cells. Lung sections from immunocompetent
mice revealed a strong pulmonary immune cell infiltration, CT
mice showed less infiltration compared to immunocompetent
mice, whereas CCT mice showed fewer infiltrating immune cells
(Figure 1C). Next, we infected immunocompetent, CCT and CT
mice with A. fumigatus conidia to determine their survival after
A. fumigatus infection. Immunocompetent mice were resistant
to infection, whereas CCT mice survived until 4 days p.i. and CT
mice survived until 7 days p.i. (Figure 1D). We hypothesized that
some immune cells would have been recruited to the infected
lungs to fight against infection in these immunocompromised
mouse models.
Neutrophils and Macrophages are
Actively Recruited to Infected Lungs in
CCT Mice
To determine the timing and magnitude of immune cell
recruitment at different stages of A. fumigatus infection in
immunocompromised CCT mice, we infected them with 1× 106
A. fumigatus conidia intranasally and analyzed defined immune
cell populations in the lungs at 4, 16, and 40 h p.i. by
flow cytometry (Supplementary Figure S1). As determined
previously, at these selected time points the fungus had evolved
through different morphotypes (conidia, germlings, and hyphae,
respectively) that would likely trigger distinct types of immune
responses. All immune populations were strongly reduced in
lungs of CCT mice when compared to the immune cells in lungs
of immunocompetent mice at steady-state-conditions (Figure 2).
Upon infection, myeloid cells, especially neutrophils (Figure 2A)
and macrophages (Figure 2B) were significantly recruited to
the lungs of CCT mice at 4 h p.i. However, cell numbers
did not surmount numbers of non-infected immunocompetent
mice under steady-state-conditions, suggesting that there were
not sufficient cells to fight against infection. Despite their low
number, these cells were strongly recruited at the 4 h p.i.
time point; but not at 16 and 40 h p.i. (Figures 2C,D). We
did not observe recruitment of other myeloid cells particularly
monocytes, dendritic cells and eosinophils in CCT mice upon
A. fumigatus infection (Supplementary Figure S2). Lymphoid
cells, particularly NK cells, CD4+ T cells and CD8+ T cells
were strongly reduced in the lungs of CCT mice and were not
recruited upon A. fumigatus infection (Figure 2E–G), suggesting
that lymphoid populations cannot play a pivotal role in the
defense against A. fumigatus under these immunosuppressive
conditions. To investigate underlying factors behind minute
immune cell infiltration in CCT mice particularly at 16 and
40 h p.i., we performed TUNEL staining to observe apoptotic
cells (Supplementary Figure S3). TUNEL positive cells appeared
in CCT mice at 16 and 40 h p.i., whereas in IC mice no
TUNEL positive cells were observed at 40 h p.i. Despite
low or reduced recruitment at 16 and 40 h after infection,
fungus growth was not controlled in CCT infected mice.
Growing hyphae in the lung tissue might lead to apoptosis of
some of the cells in CCT mice even at 40 h after infection,
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FIGURE 2 | Immune cell response in cyclophosphamide and cortisone treated (CCT) mice after A. fumigatus infection. Flow cytometry of lungs from
non-infected (NI) or infected (I) with 1 × 106 A. fumigatus conidia immunocompetent (IC) and CCT mice at indicated time points, (A) In vivo lung neutrophil and (B)
macrophage recruitment 4 h after A. fumigatus infection. (C) In vivo lung neutrophil recruitment 4, 16, and 40 h after A. fumigatus infection. (D) In vivo lung
macrophage recruitment 4, 16, and 40 h after A. fumigatus infection. (E) In vivo lung NK cell, (F) CD4+ T cell (G) CD8+ T cell recruitment 4 h after A. fumigatus
infection. Data are pooled from three independent experiments with at least n = 3/group of mice in each experiment. Unpaired Mann–Whitney u-test was utilized to
determine significant differences: ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001.
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FIGURE 3 | Host immune cell response in corticosteroid treated (CT)
mice after A. fumigatus infection. Flow cytometric analysis of lungs from
immunocompetent (IC) and CT mice non-infected (NI) or infected (I) with
1 × 106 A. fumigatus conidia were euthanized at indicated time points. (A) In
vivo neutrophil, (B) macrophage, (C) dendritic cell, and (D) monocyte
recruitment to the lung at 4 h p.i. (E–H) In vivo recruitment of immune cells to
the lung at 4, 16, and 40 h. p.i.: (E) neutrophils, (F) macrophages, (G)
dendritic cells, and (H) monocytes. Data are pooled from three independent
experiments with at least n = 3/group of mice in each experiment. Unpaired
Mann–Whitney u-test was utilized to determine significant differences:
∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001.
whereas in IC infected mice until 40 h fungus might have
been cleared and no apoptotic cells were found in TUNEL
staining.
Myeloid Cells are Strongly Recruited to
the Infected Lungs in CT Mice
Corticosteroids are widely used immunomodulatory drugs in
patients for a variety of clinical conditions (Shaikh et al., 2012).
Corticosteroid treated mouse models are also employed to
determine virulence of A. fumigatus mutants (Grahl et al., 2011).
The phagocyte recruitment in corticosteroid treated mice after
A. fumigatus infection had been previously studied (Duong et al.,
1998; Balloy et al., 2005); however, the temporal kinetics of
this dynamic immune cell response after A. fumigatus infection
remains poorly defined. To determine the local host immune
responses against A. fumigatus infection in CT mice, we infected
CT mice with A. fumigatus conidia and analyzed immune
cell recruitment at the above-specified time points of fungal
development. Myeloid cells, particularly neutrophils (Figure 3A),
macrophages (Figure 3B), dendritic cells (Figure 3C) and
monocytes (Figure 3D) were recruited to the lungs of CT infected
mice at 4 h p.i. Myeloid cell recruitment to lungs of infected mice
was high at 4 h p.i. and low at 16 and 40 h p.i. (Figures 3E–H).
Lymphoid cells were significantly reduced under these conditions
and not recruited upon A. fumigatus infection (Supplementary
Figure S4).
Myeloid Cell Recruitment to Infected
Lungs in CT Mice Correlates with
Increase in Inflammatory Lung Cytokine
Levels
Myeloid cells were strongly recruited to the infected lungs in
corticosteroid treated mice. To determine the lung cytokine
environment at different time points after A. fumigatus infection
in corticosteroid treated mice, we measured inflammatory
cytokines in lung homogenates of immunocompetent, CT
infected and non-infected mice. At 4 h p.i. the amount of the
inflammatory cytokines MCP-1, IFN-γ, TNF-α, IL-6, and IL-12
in CT infected mice significantly exceeded cytokine levels in CT
non-infected mice (Figure 4A). At 40 h p.i. the levels of lung
inflammatory cytokines, except IFN-γ were similar in both CT
infected and non-infected mice. However, the amount of the
anti-inflammatory cytokine IL-10 was significantly higher in CT
infected mice compared to non-infected mice at both 4 and 40 h
after infection (Figure 4B). In contrast to CT mice, inflammatory
or anti-inflammatory cytokines were below detection limits to
determine in lungs of CCT mice with or without infection by
the multiplex assay. Strikingly, these results suggest that increased
inflammatory response in CT mice after infection is accompanied
by high lung myeloid cell recruitment to the CT infected lungs.
Adoptively Transferred CD11b+ Myeloid
Cells Rescue Cyclophosphamide
Immunosuppressed Mice from Lethal
A. fumigatus Infection
Regardless of the immune status of mice, myeloid but
not lymphoid cells were recruited to the site of infection.
Despite their strongly reduced immune cell numbers, this
was also true for the lungs of CCT mice after A. fumigatus
Frontiers in Microbiology | www.frontiersin.org 7 July 2016 | Volume 7 | Article 1107
fmicb-07-01107 July 11, 2016 Time: 17:55 # 8
Kalleda et al. Aspergillus fumigatus and Immune Response
FIGURE 4 | Inflammatory cytokine response in corticosteroid treated (CT) mice after challenge with A. fumigatus conidia. Cytometric Bead Array of lung
homogenates from non-infected (NI) or with 1 × 106 A. fumigatus conidia infected (I) immunocompetent (IC) and CT mice. (A) In vivo lung cytokine environment at
4 h after A. fumigatus infection. (B) In vivo lung cytokine environment at 40 h p.i. Data are representative of two independent experiments with n = 3 mice/group in
each experiment. Unpaired Mann–Whitney u-test was utilized to determine significant differences: ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001.
infection. To determine whether myeloid cells alone can
rescue immunosuppressed mice from lethal A. fumigatus
infection we adoptively transferred CD11b+ myeloid cells
into immunosuppressed mice that had been treated with
cyclophosphamide (150 mg/kg) on days -3 and -1 (Figure 5A)
alone, since corticosteroid models might interfere with antifungal
functions of myeloid cells, as CT infected mice were not resistant
to infection irrespective to strong myeloid cell recruitment to
the lungs. CD11b+ myeloid cells were enriched from bone
marrow of BALB/c donor mice (Figure 5B) and transfused
intravenously to cyclophosphamide immunosuppressed (C
IS) mice on day 0. This CD11b+ population consisted of
CD11b+Ly6Ghigh neutrophils (70 ± 1%), CD11b+Ly6Gdim
cells (5 ± 0.5%), CD11b+Ly6G−Ly6C+ monocytes (7 ± 1%)
and CD11b+Ly6G−Ly6C− non-differentiated neutrophilic and
monocytic precursor cells (18 ± 4%, Supplementary Figure S5).
On day +1 we infected mice with a lethal dose of 2 × 105
A. fumigatus conidia and monitored their survival (Figure 5C).
C IS mice, which had received an adoptive CD11b+ myeloid
cell transfer, were resistant to a lethal infection dose, whereas,
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FIGURE 5 | Adoptive CD11b+ myeloid cell transfer protects cyclophosphamide immunosuppressed mice from lethal A. fumigatus infection.
(A) Experimental setup for adoptive CD11b+ myeloid cell transfer and A. fumigatus infection. Mice were immunosuppressed with cyclophosphamide on day -3 and
day -1. On day 0, cyclophosphamide immunosuppressed (C IS) mice were injected with 5 × 106 cells CD11b+ myeloid cells/mouse i.v. Subsequently, mice were
(Continued)
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FIGURE 5 | Continued
intranasally infected with a lethal dose of A. fumigatus conidia (2 × 105 conidia/mouse). (B) Purity of CD11b+ myeloid cells measured with flow cytometry after
enrichment from bone marrow of tibia and femur bones. Cell purity always exceeded 95%. (C) Survival of C IS mice after A. fumigatus infection. C IS mice that had
been transfused with CD11b+ myeloid cells completely resist an otherwise lethal A. fumigatus infection (P = 0.0003). All groups n = 8. Data are representative of
three independent experiments n = 8/group of mice in each experiment. Log-rank (Mantel–Cox) test was utilized to determine survival significance.
(D) Bioluminescence imaging. CD11b+ myeloid cells were enriched from L2G85 luciferase reporter mice and transfused to C IS mice and infected with TdTomato
expressing A. fumigatus. Ex vivo bioluminescence imaging was performed 3 days p.i. n = 2 mice/ group. (E) Immunofluorescence microscopy at 3 days p.i. of lungs
from C IS mice after transfused with luciferase expressing CD11b+ myeloid cells and infected with Afu-TdTomato conidia. A. fumigatus in red, anti-luciferase staining
of transfused CD11b+ cells in green and DAPI staining for nuclei in blue color. Scale bar 20 µM.
immunosuppressed and infected (control) mice were unable
to clear the infection and died within 4 days after infection
(Figure 5C). To determine whether transfused CD11b+ myeloid
cells recruit to the infected lungs and directly impair A. fumigatus
growth, we performed an adoptive cellular transfer experiment
with transgenic firefly luciferase expressing CD11b+ myeloid
cells enriched from a BALB/c.L2G85 luciferase reporter mouse
(Cao et al., 2004; Beilhack et al., 2005) and infected with
TdTomato expressing A. fumigatus conidia with the same
experimental settings as described in Figure 5. The transfused
CD11b+ cells were detected in C IS infected and not infected
lungs 3 days p.i. with ex vivo bioluminescence imaging (Chopra
et al., 2015). Lungs from transfused and infected C IS mice
contained many CD11b+ cells, whereas lungs from transfused
and not infected C IS mice did not show CD11b+ myeloid
cells (Figure 5D). To determine whether recruited CD11b+
myeloid cells interacted with A. fumigatus, we performed
fluorescence microscopy on C IS transfused and infected lung
sections. Luciferase expressing CD11b+ cells were found in close
proximity to A. fumigatus and fungal hyphal formation was
impaired at 3 days p.i. (Figure 5E). These results indicate that
adoptively transferred CD11b+ cells recruit to the infected lungs
and support locally the control of A. fumigatus fungal growth.
In contrast, cortisone and cyclophosphamide immunosuppressed
(CC IS) mice, which had received adoptively transferred CD11b+
myeloid cells, could not clear the infection and died within 5 days
after infection (Figures 6A,B). CC IS mice which had received
luciferase expressing CD11b+ myeloid cells showed strong influx
of these cells to the lungs upon infection (Figure 6C). However,
these strongly recruited cells failed to control of A. fumigatus
growth in CC IS infected lungs (Figure 6D). These striking
results indicate that corticosteroid treatment might either have
caused tissue damage to recipient mice or affected the protective
function of adoptively transferred CD11b+ myeloid cells.
However, myeloid cells significantly contributed to the host anti-
A. fumigatus defense as adoptive transfer of CD11b+ myeloid
cells alone rescued cyclophosphamide immunosuppressed mice
from lethal A. fumigatus infection.
DISCUSSION
The pivotal role of the innate immune system eliminating
A. fumigatus conidia in healthy individuals has long been
well-recognized (Balloy and Chignard, 2009). The anatomical
and physiological barriers of the respiratory tract restrict most
of the airborne conidia to reach alveolar spaces, however,
the small size and hydrophobic nature of conidia, strongly
favors some of them to cross alveolar epithelia and reach
alveolar spaces (Margalit and Kavanagh, 2015). Most of
the conidia in alveolar spaces are eradicated by resident
phagocytes without any further development of antibody-or-
cell mediated acquired immunity (Park and Mehrad, 2009).
However, a compromised immune system provide the basis
for germination of A. fumigatus conidia and subsequent lung
infections (Margalit and Kavanagh, 2015). In the last few
decades, several studies defined the anti-A. fumigatus functions
of innate or adaptive immune cells (Cramer et al., 2011; Sales-
Campos et al., 2013). Most of the in vivo studies focused
on depleting a defined immune cell population from healthy
murine models to determine the consequences of loss of
distinct cell populations on survival and overall outcome of the
disease. Nevertheless, to improve management and treatment
of A. fumigatus lung infections in immunocompromised
patients it is essential to study host pathogen interactions
in murine models of aspergillosis that mimic scenarios of
immunocompromised patients. Moreover, corticosteroid treated
(CT) and corticosteroid and cyclophosphamide treated (CCT)
mice are often used for virulence analysis of A. fumigatus
mutants. CT or CCT models are selected for virulence analysis
depending on the observed phenotype of the fungal mutant,
for instance CT models are often used for virulence analysis of
auxotroph mutants and CCT models for oxidative stress mutants
(Sheppard et al., 2005; Chiang et al., 2008; Spikes et al., 2008;
Amich et al., 2013; Staats et al., 2013). However, the immune
status of these models under steady-state and infected conditions
remained largely elusive.
Here, we employed these two clinically relevant
immunocompromised murine models to study the host
immune responses after A. fumigatus challenge. In the CCT
model, mice received the combination of cyclophosphamide
and corticosteroid treatment. This combination is widely used
in treating patients with idiopathic pulmonary fibrosis (Collard
et al., 2004; Kawasumi et al., 2015), acute/subacute interstitial
pneumonia (Kameda et al., 2005), refractory optic neuritis in
Wegener’s granulomatosis (Huchzermeyer et al., 2013) and
light chain (AL) amyloidosis (Palladini et al., 2015). However,
treatment with this combination is widespread across several
clinical situations; the risk of A. fumigatus infections associated
with this treatment and immune cell responses after A. fumigatus
infection during the treatment remained poorly defined. We
confirmed that CCT mice were highly susceptible to A. fumigatus
infection and died from infection within 4 days after A. fumigatus
challenge. Severe leukopenia permits rapid colonization of
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FIGURE 6 | Adoptively transferred CD11b+ myeloid cells do not protect from A. fumigatus infection if mice are immunosuppressed with both,
cyclophosphamide and corticosteroids. (A) Experimental setup for adoptive CD11b+ myeloid cell transfer and A. fumigatus infection. Mice were
immunosuppressed with both, cyclophosphamide & cortisone on day -3 and day -1 (CC IS mice). On day 0, CC IS mice received 5 × 106 CD11b+ myeloid cells i.v.
(Continued)
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FIGURE 6 | Continued
and were intranasally infected with a lethal dose of 2 × 105 A. fumigatus conidia to determine survival. (B) Survival of mice after adoptive CD11b+ myeloid cell
transfer. Adoptive CD11b+ myeloid cell transfer does not protect CC IS mice from lethal A. fumigatus infection. No differences deemed significant [Log-rank
(Mantel–Cox test)] between infected CC IS mice, and infected CC IS mice that had been transfused with CD11b+ myeloid cells. Data are representative of two
independent experiment with n = 8/group of mice in each experiment. (C) Bioluminescence imaging. CD11b+ myeloid cells were enriched from L2G85 luciferase
reporter mice and transfused into CC IS mice and infected with TdTomato expressing A. fumigatus. Ex vivo bioluminescence imaging was performed 3 days p.i.
n = 2 mice/group. (D) Immunofluorescence microscopy of lungs from CC IS mice that had received luciferase expressing CD11b+ myeloid cells and were infected
with Afu-TdTomato conidia at 3 days p.i. A. fumigatus in red, anti-luciferase staining for transfused CD11b+ cells in green and DAPI staining for nuclei in blue color.
Scale bar 20 µM.
A. fumigatus characterized by elongated hyphae in lung tissue
40 h after infection resulting in death of CCT infected mice
within 4 days after infection, which is consistent with previous
findings (Amich et al., 2013). Nevertheless, despite their strongly
reduced number, myeloid cells, particularly neutrophils and
macrophages were recruited to the infected lungs in CCT mice.
Myeloid cell numbers in the lungs of CCT infected mice did
not exceed numbers found in lungs of immunocompetent mice
under steady-state conditions, which indicates that there were
not sufficient myeloid cells recruited to the infected lungs in
CCT mice to clear the infection or prolong the life span of CCT
mice. Inflammatory cytokine responses are crucial for properly
resolving an A. fumigatus lung infection (Chotirmall et al., 2013),
for instance, TNFα initially released from alveolar macrophages
and later by recruited neutrophils and monocytes is important
to clear A. fumigatus infection (Mehrad et al., 1999a,b; Brieland
et al., 2001; Palladino et al., 2003). Other proinflammatory
cytokines, such as IL-6, MCP-1, and IFNγ have been described
as vital to eliminate pulmonary A. fumigatus infections (Blease
et al., 2001; Brieland et al., 2001; Cenci et al., 2001). All the
above-mentioned cytokines were undetectable in CCT mice,
both, under steady-state conditions as well as after A. fumigatus
infection. These results support the strong immunosuppressive
action of high-doses of cyclophosphamide causing the high
susceptibility of CCT mice to lethal A. fumigatus infection. The
combination of cyclophosphamide and corticosteroid treatment
strongly reduced lymphoid cells in CCT mice and no lymphoid
cells were recruited upon infection. Infection related risk is very
high with this type of treatment and clinicians might need to
take special precautions to avoid infections by A. fumigatus
throughout the treatment period.
Corticosteroids are widely prescribed drugs in several clinical
situations (Barnes, 2006; Emadi et al., 2009). We showed that
corticosteroid treated mice survived for 7 days after A. fumigatus
challenge, which correlates with greater myeloid cell recruitment
and inflammatory lung cytokines such as MCP-1, IFN-γ, TNFα
and IL-6 levels in the infected lungs. However, survival after
infection was not greatly improved when compared to CCT
infected mice suggesting that corticosteroids may rather affect
anti-fungal functions of immune cells than influencing direct
myeloid cell recruitment. Clearly, further studies are warranted to
completely understand the effects of corticosteroids on myeloid
cells on anti-A. fumigatus defense functions. Our results are also
in line with the observation that corticosteroid treatment causes
strong inflammation, which might enhance tissue damage after
infection (Ibrahim-Granet et al., 2010; Grahl et al., 2011) leading
to death within 7 days after infection. Overall, in both, CCT and
CT models myeloid but not lymphoid cell infiltration of the lungs
dominated after A. fumigatus infection.
Importantly, CD11b+ myeloid cells alone rescued
cyclophosphamide immunosuppressed mice from lethal
A. fumigatus infection. The adoptive transfer of common myeloid
progenitors (CMP) and granulocyte-monocyte progenitors
(GMP) protected mice against disseminated A. fumigatus
infections (BitMansour et al., 2002). This protection was only
conferred when mice were infected on day +7 (67% survival)
or day +11 (100% survival) after transplantation. None of the
mice survived when infected on day +3 after transplantation
(BitMansour et al., 2002). The adoptive transfer of common
myeloid progenitor cells bears the benefit to provide immune-
reconstitution for longer time periods, yet their requirement
to firstly home to the bone marrow for further development
into mature effector cells delays the host defense against
A. fumigatus infection. The adoptive transfer of bulk CD11b+
myeloid cells bears the advantage that it is technically simple to
achieve through enrichment with magnetic beads and it proved
effective to provide early protection from an otherwise lethal
A. fumigatus infection. The surface receptor CD11b (integrin
alpha M, ITGAM) subunit forms the heterodimeric integrin
αMβ2 integrin, which is expressed on a variety of myeloid cells
including neutrophils, monocytes, and macrophages. These
immune populations play a pivotal role in defense against lethal
A. fumigatus lung infections (Balloy and Chignard, 2009). For
instance, the myeloid subset of neutrophils has been shown to be
critical in controlling A. fumigatus infection (Feldmesser, 2006).
The timing of neutrophil recruitment is vital for A. fumigatus
clearance as a small delay in neutrophils arrival leads to increased
disease susceptibility (Mehrad et al., 1999a; Bonnett et al.,
2006). Macrophages are effective phagocytic cells and important
for fungal pathogen clearance (Bhatia et al., 2011). Finally,
circulating monocytes are major precursor cells, once they
become activated with the infectious stimulus they develop into
macrophages and dendritic cells (monocyte derived dendritic
cells) and play an important role in elimination of A. fumigatus
infections (Espinosa et al., 2014). The CD11b+ myeloid cells
were transfused into immunosuppressed mice and then infected
with A. fumigatus. However, particularly for the purpose of
clinical translation, it might be interesting to perform future
adoptive transfer experiments in mouse models with already
established invasive aspergillosis. In clinical scenarios, cellular
immunotherapy still remains an intriguing therapeutic option
for patients suffering from invasive A. fumigatus infections
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who do not respond to conventional antifungal drugs.
Our adoptive CD11b+ myeloid cell transfer experiments
provide a basis for the future development of novel
myeloid based immunotherapy. Clearly, further experiments
are required to establish the optimal dosage and timing
for CD11b+ myeloid cell transfusion to treat already
established invasive infections and to address transfusion
related side effects. In contrast to effective infection control
after adoptive CD11b+ myeloid cell transfer into otherwise
highly susceptible cyclophosphamide treated mice, adoptive
CD11b+ myeloid cell transfer did not protect corticosteroid
and cyclophosphamide immunosuppressed mice from lethal
infection. This clearly suggests that corticosteroid treatment
enhances inflammation mediated tissue damage or impairs
antifungal functions of myeloid cells. Further studies are
warranted to dissect these mechanisms and to address the
effects of corticosteroids on antifungal functions of immune cell
subsets.
Collectively, we provided a comprehensive analysis of immune
cell responses after A. fumigatus infection in two clinically
relevant immunocompromised mouse models. These models
of invasive aspergillosis along with detailed information of
immune cell response after A. fumigatus infection might also
help in testing the efficacy of non-conventional novel anti-
fungal therapies to treat invasive A. fumigatus infections,
for instance new small molecule inhibitors, antibodies or
therapeutic RNAs (Kalleda et al., 2013). Since we showed
successful control of A. fumigatus infection after adoptive
transfer of CD11b+ myeloid cells into cyclophosphamide
immunosuppressed mice, our results confirm that CD11b+
myeloid cells are major contributors to fight against A. fumigatus
lung infections in immunocompromised conditions. These
results may further support the future development of novel
myeloid-based immunotherapies against opportunistic fungal
infections.
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